A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic

BACKGROUND: The COVID-19 pandemic disrupted access to treatment for substance use disorders (SUDs), while alcohol and cannabis retail sales increased. During the pandemic, we tested a tailored digital health solution, Woebot-SUDs (W-SUDs), for reducing substance misuse. METHODS: In a randomized cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Prochaska, Judith J., Vogel, Erin A., Chieng, Amy, Baiocchi, Michael, Maglalang, Dale Dagar, Pajarito, Sarah, Weingardt, Kenneth R., Darcy, Alison, Robinson, Athena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423936/
https://www.ncbi.nlm.nih.gov/pubmed/34507061
http://dx.doi.org/10.1016/j.drugalcdep.2021.108986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423936/
https://www.ncbi.nlm.nih.gov/pubmed/34507061
http://dx.doi.org/10.1016/j.drugalcdep.2021.108986

Ejemplares similares